New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.
New real-world evidence on the MSDA Test published in The Multiple Sclerosis Journal – ET&C. Read the press release.
How influential is the MSDA Test to clinical decision making in the opinion of the clinician?
The MSDA Test significantly impacts decisions at meaningful decision timepoints.
With continued use of the test, the MSDA aided in the clinicians’ decisions to start, stop or switch DMT and/or order additional lab or MRI tests.
A total of 352 charts which included 723 MSDA tests were reviewed. The proportion of decision time points where clinicians “strongly agreed” or “agreed” that MSDA results influenced their decision-making was greater when multiple longitudinal MSDA results were available compared to a single MSDA result: 69.2% (p<0.001; 95%CI: [60.2, 78.3]%) vs. 59.8% (p=0.217; 95%CI: [43.7, 76]%), respectively (FIGS. 2 & 3).
